ARROWHEAD PHARMACEUTICALS, INC. — Director's Dealing 2024

Dec 21, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
CIK: 0000879407
Period of Report: 2024-12-18

Reporting Person: PERRY MICHAEL S (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-12-18	Common Stock	A	16733	$22.99	Acquired	131490	Direct

Footnotes

F1: Represents shares underlying restricted stock units, which shares will vest in one installment on the first anniversary date.